Septerna, Inc.
Septerna, Inc. (SEPN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SEPN · as of Jun 8, 2026
Key Statistics
Explore Septerna, Inc. Data
sepn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The SEPN analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $45.50, representing +47.56% upside from the current price of $30.84.
Competitors & Peers
sepn competitorsSEPN
ABUS
BCAX
EYPT
FTRE
KURAStock Performance
Full HistoryAbout Septerna, Inc.
Septerna, Inc. a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology …
what is septerna, inc. · sepn stock overview · septerna, inc. company profile · who is septerna, inc. ceo · sepn NASDAQ · septerna, inc. headquarters · septerna, inc. business segments
About Stock Overview & Key Data
Septerna, Inc. (SEPN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 25, 2024. As of the latest trading session, SEPN stock price is $30.84, with a market capitalization of $1.4B. The stock has returned +206.81% over the past 12 months and +11.26% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Septerna, Inc. stock is Buy, with an average 12-month price target of $45.50. In fiscal year 2025, Septerna, Inc. reported revenue of $46.0M and net income of -$48.9M. For detailed data — including Septerna, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Septerna, Inc. (SEPN) stock price is $30.84. The stock is traded on NASDAQ under the ticker symbol SEPN. The 52-week range is $9.70 – $32.63.